ArticleBioengineered2022

Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.

Yitian Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.